|
|
||||||||
J Thorac Cardiovasc Surg 2000;120:224-229
© 2000 The American Association for Thoracic Surgery
Surgery for congenital heart disease |
From the Department of Pediatric Cardiology and Cardiac Surgery, Royal Brompton Hospital,a London, United Kingdom, and the Department of Biostatistics, Childrens Hospital,b Boston, Mass.
Address for reprints: Elliot A. Shinebourne, FRCP, Department of Pediatric Cardiology, Royal Brompton Hospital, Sydney St, London SW3 6NP, United Kingdom.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
30 days) and 60 (32%) infants. Sixty-four (35%) were girls, and 121 (65%) were boys. Fifty-two (28%) patients underwent an operation between 1974 and 1985, and 133 (72%) patients underwent an operation between 1986 and 1998. The median age at the time of the operation was 18 days. The median age for the neonates was 8 days. The median weight for all patients was 3.6 kg (range, 1.2-10.0 kg), and the median weight for neonates was 3.3 kg (range, 1.2-5.6 kg). Diagnosis of coarctation of the aorta in all patients was the indication for surgical treatment. This diagnosis was made in all patients by transthoracic echocardiography. Eighteen (10%) patients also underwent cardiac catheterization. Catheterization was performed in the earlier part of the study and in patients with associated cardiac anomalies. Sixty-three (34%) patients were receiving alprostadil (prostaglandin) infusions before the operation. Twenty-two (12%) patients were in heart failure and required assisted ventilation before the operation. None of the patients had evidence of a cerebral hemorrhage. Four (2%) patients had sepsis confirmed by positive blood cultures.
Associated cardiac anomalies
Associated cardiac anomalies are shown in Table I. Ventricular septal defects (VSDs) were classified according to their size and number; small, moderate, or large size (nonlimiting); and single or multiple status.
|
Surgical technique
Before the operation, pressure was measured in the right radial artery and the right or left femoral artery. All patients underwent repair through a left-sided posterolateral thoracotomy. The aortic arch, subclavian artery, aortic isthmus, and descending thoracic aorta were exposed and dissected free. The ductus was divided, clipped, or both, with a clip (Ligaclip; Ethicon Endo-Surgery, Cincinnati, Ohio). The left subclavian artery was ligated in its very distal segment before its first branch. An incision was made just over the descending thoracic aorta distal to the coarctation of the aorta area. This is extended across the coarctation area into the subclavian artery. We extended the aortotomy at least 5 mm distal to the coarctation of the aorta, so that the distal end of the aortotomy (ie, the site of the distal anastomosis) does not lie opposite the ductal area. Before anastomosing the flap, we excised any excessive ductal tissue that protruded into the lumen of the aorta. All operations were performed by this technique. A single surgeon (C.L.) operated on 128 (69%) patients and his trainees operated on the remaining 57 (31%) patients.
Follow-up in the early postoperative period
Seventy-four (40%) patients underwent transthoracic echocardiography before discharge from the hospital.
Follow-up after hospital discharge
All patients were seen by the referring cardiologist at The Royal Brompton Hospital or by one of the cardiologists in an outreach clinic. Follow-up was complete and up to date in all patients.
Recoarctation
Recoarctation was assessed by means of clinical examination, transthoracic echocardiography, or both. Recoarctation was defined when the arm-leg blood pressure difference was greater than 20 mm Hg or if a gradient of more than 25 mm Hg was noted by means of transthoracic echocardiography, the presence of a diastolic tail to the continuous wave Doppler signal in the descending aorta, or both.
4
Statistical analysis
The outcome variables were survival and recoarctation. Univariate analyses for categoric predictors were evaluated by the Fisher exact test. Actuarial estimates for survival and freedom from recoarctation with 95% Greenwood confidence intervals (CIs) were determined by the Kaplan-Meier product-limit method. Survival curves were compared by the log-rank test.
6 The Cox proportional hazards regression model was used to establish the variables that were independently associated with each outcome, with risk measured by the hazard ratio using 95% confidence limits.
7 For survival analysis, recoarctation was tested as a time-dependent covariate in the Cox model. Other covariates included age as both a continuous and categoric (neonates vs infants) variable, sex, year of operation, and weight as continuous variables, and surgeon, presence or absence of sepsis, associated cardiac anomalies, arch hypoplasia, and alprostadil (prostaglandin) infusion as categoric variables. A forward stepwise selection procedure was used to construct the final multivariate models, and a significance level of .05 was required for a variable to be retained as a risk factor in the model. The SAS software package version 6.12 was used for all statistical analysis (SAS Institute, Cary, NC).
| Results |
|---|
|
|
|---|
|
|
Recoarctation
Eleven (6%) patients had recoarctation after a median time of 6.2 years (6.2 ± 4.6 years). The freedom from recoarctation at 2 years was 95% (95% CI, 92%-98%), and at 5, 10, and 15 years, it was 92% (95% CI, 88%-96%; Fig 2). This is also shown in Fig 3, where neonates and infants are compared. Results obtained by the Cox multivariable regression established 3 independent risk factors associated with recoarctation: persistent arch hypoplasia after the operation (P = .01), year of operation (P = .03), and age as a continuous variable (P < .001). None of the other variables were significantly associated with recoarctation in the Cox multivariate analysis (P > .1 in each case). Regression coefficients, SEs, hazard ratios, and 95% CIs are shown in Table II. As shown in Table II
, the more recent operations, reflected by a negative coefficient and a hazard ratio of less than 1, are associated with lower risk of survival and recoarctation. The details of the 11 patients who had recoarctation and required reintervention are shown in Table III. Three patients had reoperation. Two of these had arch hypoplasia diagnosed preoperatively, and this was persistent at follow-up. However, the recoarctation was at the distal site of the anastomosis. Repair was performed by resection and end-to-end anastomosis. Eight underwent balloon dilatation. Follow-up was complete in all these patients, with a median time of 6.5 years (range, 1-11 years). In all patients after reintervention, the postintervention gradient was less than 20 mm Hg. This was demonstrated in all patients by transthoracic echocardiography and confirmed in 6 patients by means of aortography.
|
|
|
Patients with VSDs
Of the 66 (36%) patients with VSDs, 17 underwent pulmonary artery banding at the time of coarctation repair. Fifteen had a large VSD, 1 had multiple VSDs, and 1 had a moderate-sized VSD. The remainder were stable and did not require concomitant pulmonary artery banding. The small-sized VSDs in 38 of the 41 patients had closed spontaneously at a median follow-up of 4.3 years. All other patients underwent surgical closure.
Surgical complications
The left arm function was not assessed formally but rather on the basis of symptoms and general appearance. None of the patients had any neurologic or ischemic complications involving the left arm, either at early or late follow-up. None had aneurysm formation. One patient was hypertensive at follow-up, requiring medication.
| Discussion |
|---|
|
|
|---|
The aim of this study was not to compare different surgical methods for the repair of coarctation of the aorta. Our policy has been to perform SFA in all neonates and small infants. In addition to reporting outcomes, the particular concern of the study was to determine whether SFA would facilitate growth of the aortic arch without the need for surgical augmentation. Recent reports have shown a trend toward forms of end-to-end anastomosis for repair of coarctation of the aorta and highlighted the potential disadvantages of SFA.
8 These include leaving the ductal tissue, which may contribute to subsequent recoarctation, the inability to relieve coexistent arch hypoplasia, the inherent disadvantage of having to sacrifice the left subclavian artery, and the possibility of an increased risk of late aneurysm formation in the abnormal tissue of the posterior aortic wall. However, these potential disadvantages are not borne out in the literature or in our data. Ziemer and colleagues
9 reported on 100 patients, 70% of whom underwent SFA and 24% of whom underwent end-to-end anastomosis repair. Freedom from reintervention for recoarctation after 5 years was not significantly different between the 2 groups. Similarly, others have shown no difference in recoarctation rates between SFA and end-to-end anastomosis.
10,11 We report a recoarctation rate of 6%. This is lower than other figures in the literature, which report rates from 9.8%
11 to 24%.
9
It is unlikely that we have underestimated our incidence of recoarctation because 146 (81%) patients underwent transthoracic echocardiography, with Doppler studies performed at the latest follow-up. Borderline cases were additionally investigated by angiography or magnetic resonance imaging. This differs from most other reports in which recoarctation was assessed by arm-leg blood pressure differences alone, and therefore in those series its incidence may have been underestimated.
One of the potential advantages of extended end-to-end anastomosis repair is the ability to deal with arch hypoplasia at the time of presentation.
12 This is clearly not the case with SFA, but adequate growth (presumably resulting from improved arch flow characteristics) was achieved in the vast majority of our patients. Nonetheless, arch hypoplasia persisted in 2% of the patients and was indeed identified as a risk factor for subsequent recoarctation, although no patients required arch augmentation. In these patients angiographic imaging of the aorta showed that recoarctation was not due to a hypoplastic transverse arch, and it was probably at the site of ductal tissue. On this basis, we concur with Sewers and colleagues
11 that in the vast majority of patients, there is no need for extensive resection and aggressive enlargement of the hypoplastic arch.
As for the treatment of patients with an associated large or moderately large VSD, we have repaired the coarctation and undertaken pulmonary artery banding at the same time. A multi-institutional study demonstrated that among patients with coexisting moderate- to large-sized VSDs, repair of coarctation of the aorta, pulmonary artery banding, and subsequent repair of the VSD were associated with the highest 2-year survival (ie, 97% in those with a single VSD).
13 In our study the patients with concomitant VSDs did not have a higher morbidity or mortality or reduced long-term survival when compared with those without a VSD.
We believe that SFA still provides an excellent method of repair for neonatal and infantile coarctation of the aorta. When properly performed in patients with simple additional defects, this technique gives rise to a low incidence of recoarctation, and adequate arch growth occurs without the need for augmentation.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. C. Fiore, L. K. Fischer, T. Schwartz, S. Jureidini, I. Balfour, D. Carpenter, D. Demello, K. S. Virgo, D. G. Pennington, and R. G. Johnson Comparison of Angioplasty and Surgery for Neonatal Aortic Coarctation Ann. Thorac. Surg., November 1, 2005; 80(5): 1659 - 1665. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Kiraly, L Kornyei, G Mogyorossy, and A Szatmari Hypoplastic aortic arch in newborns rapidly adapts to post-coarctectomy circulatory conditions Heart, February 1, 2005; 91(2): 233 - 234. [Full Text] [PDF] |
||||
![]() |
H. Ince, M. Petzsch, T. Rehders, S. Kische, T. Korber, F. Weber, and C. A. Nienaber Percutaneous Endovascular Repair of Aneurysm After Previous Coarctation Surgery Circulation, December 16, 2003; 108(24): 2967 - 2970. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Rokkas, S. F. Murphy, and N. T. Kouchoukos Aortic coarctation in the adult: Management of complications and coexisting arterial abnormalities with hypothermic cardiopulmonary bypass and circulatory arrest J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 155 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-A. Elgamal, E. D. McKenzie, and C. D. Fraser Jr Aortic arch advancement: the optimal one-stage approach for surgical management of neonatal coarctation with arch hypoplasia Ann. Thorac. Surg., April 1, 2002; 73(4): 1267 - 1273. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Isomatsu, Y. Imai, T. Shin'oka, M. Aoki, and K. Sato Coarctation of the aorta and ventricular septal defect: Should we perform a single-stage repair? J. Thorac. Cardiovasc. Surg., September 1, 2001; 122(3): 524 - 528. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |